Schedule 13G ownership disclosure
Minerva Neurosciences, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 603380205
Event date: 2025-12-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Vivo Opportunity Fund Holdings, L.P.
Shares: 8,591,572.00 · Class: 9.99%
- Vivo Opportunity, LLC
Shares: 8,591,572.00 · Class: 9.99%
- Vivo Opportunity Cayman Fund, L.P.
Shares: 868,428.00 · Class: 9.99%
- Vivo Opportunity Cayman, LLC
Shares: 868,428.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-127135
- Form type
- SCHEDULE 13G
- Filer
- Minerva Neurosciences, Inc.
- CIK
- CIK 1598646
- Filed
- Dec 31, 2025
- Reporting period
- Dec 23, 2025
- Description
- Schedule 13G beneficial ownership